Alfred Ian Lee MD, PhD

Assistant Professor of Medicine (Hematology); Firm Chief, Inpatient Hematology, Yale Cancer Center; Assistant Program Director, Traditional Internal Medicine Residency Program

Clinical Interests

Lymphoma; platelet disorders; thrombosis; bleeding; coagulation disorders; leukemia


Board Certifications

2007
Internal Medicine, Board Certified
2013
Hematology, Internal Medicine, Board Certified

Patient Care Locations

alfred_leefaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Hepatic Veno-Occlusive Disease, Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, and Non-Hodgkin's LymphomaDefibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
Hemophilia AAn ascending single dose study to evaluate the safety, tolerability and pharmacokinetics/pharmacodynamics of PF-05280602, a recombinant factor VIIa variant (813D), in adult hemophilia A and B subjects with or without inhibitors.
Leukemia, not otherwise specified and Myeloid and Monocytic LeukemiaA Phase 1-2, Dose Escalation, Multicenter Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects with Intermediate or High-Risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
Antiphospholipid Syndrome (APS)Comparison of Gut Commensal Bacteria Between Persistently anti-gamma2 Glycoprotein-I Positive Patients and Antiphospholipid Antibody Negative Patients
Ill-Defined Sites and Unknown SitesA Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

More Clinical Trials...

Edit Profile